Long-Term Loans Payable (Details) - USD ($) |
Jan. 01, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Sep. 30, 2020 |
|---|---|---|---|---|
| Long-Term Loans Payable [Line Items] | ||||
| Outstanding current balance | $ 448,155 | |||
| Outstanding balance | $ 431,079 | |||
| Cordyceps Sunshine Biotech Co., Ltd. [Member] | ||||
| Long-Term Loans Payable [Line Items] | ||||
| Loan agreements | $ 414,000 | |||
| Interest rate | 4.125% |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average effective interest rate during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|